Gerresheimer slumps over 23% after forecasting modest Q2 growth

Gerresheimer AG (GXI) shares declined approximately 7% following a revised 2025 outlook, projecting low single-digit organic revenue growth for Q2 and 1-2% for the full year, with an adjusted EBITDA margin around 20%. The company also significantly reduced its 2024 dividend from EUR 1.25 to EUR 0.04 per share and anticipates a low double-digit percentage decrease in adjusted EPS for 2025, a marked shift from the previous year's high single-digit percentage growth.

Analysis

Gerresheimer AG (GXI) shares experienced a significant decline of approximately 7% following the company's downward revision of its 2025 guidance. The updated outlook anticipates organic revenue growth in the low single-digit range for Q2 2025 and a modest 1-2% for the full year 2025. Concurrently, the adjusted EBITDA margin is now expected to be around 19% for Q2 2025 and approximately 20% for the full year, a decrease from the previously projected 22%. A particularly impactful change is the substantial reduction in the 2024 dividend from EUR 1.25 per share to EUR 0.04. Furthermore, Gerresheimer forecasts a low double-digit percentage decrease in adjusted EPS for 2025, marking a stark contrast to the high single-digit percentage growth achieved in the previous year. The company's supervisory board is scheduled to discuss these new guidance adjustments and the dividend proposal on June 5, 2025. This revision signals a challenging near-term operational and financial environment for the company.

Key Decisions for Investors

• Investors should exercise caution due to the significant negative revisions across Gerresheimer's key financial metrics, including revenue growth, EBITDA margin, and adjusted EPS, which indicate deteriorating fundamentals.
• The drastic dividend cut from EUR 1.25 to EUR 0.04 per share signals potential cash flow constraints or a strategic shift in capital allocation, warranting close scrutiny.
• Monitor the outcome of the supervisory board meeting on June 5, 2025, for further clarification on the revised outlook and dividend policy, which could provide critical insights into the company's future trajectory.
• Re-evaluate investment theses in GXI, considering the shift from expected growth to a projected decline in adjusted EPS, and assess the potential for further downside risk until greater clarity on operational recovery emerges.